Skip to main content
. Author manuscript; available in PMC: 2021 Jan 26.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Jul 1;75(Suppl 3):S281–S287. doi: 10.1097/QAI.0000000000001403

TABLE 3.

Prevalence Ratios Comparing MSMO and MSMW for Selected Outcome Variables, NHBS, 2011 and 2014

Unadjusted
Prevalence Ratio
(95% CI)
aPR
(95% CI)
Condomless anal sex with male sex partners, last 12 mo n = 17,181 n = 16,935
  MSMO Ref Ref*
  MSMW 0.78 (0.75 to 0.82) 0.77 (0.74 to 0.81)
Gave money or drugs in exchange for sex, last 12 mo n = 17,175 n = 16,929
  MSMO Ref Ref
  MSMW 3.79 (3.34 to 4.29) 2.85 (2.52 to 3.24)
Received money or drugs in exchange for sex, last 12 mo n = 17,174 n = 16,928
  MSMO Ref Ref
  MSMW 4.31 (3.91 to 4.76) 2.64 (2.37 to 2.93)
Diagnosed with another STD, last 12 mo n = 17,207 n = 16,963
  MSMO Ref Ref
  MSMW 0.88 (0.77 to 1.01) 0.83 (0.72 to 0.95)
Ever injected drugs n = 17,202 n = 16,958
  MSMO Ref Ref§
  MSMW 2.33 (2.04 to 2.67) 2.05 (1.80 to 2.34)
Tested for HIV, last 12 mo n = 14,981 n = 14,751
  MSMO Ref Ref§
  MSMW 0.95 (0.92 to 0.99) 0.98 (0.95 to 1.02)
Out to health care provider n = 17,170 n = 16,859
  MSMO Ref Ref
  MSMW 0.64 (0.61 to 0.67) 0.73 (0.69 to 0.77)

Prevalence ratios estimated from log-linked Poisson regression with generalized estimating equations clustered on recruitment event.

*

Adjusted for age, income, and ever injected drugs.

Adjusted for age, education, income, and ever injected drugs.

Adjusted for age and income.

§

Adjusted for age, education, and income.

Adjusted for education, income, sexual identity, and current health insurance.